Gerhard Ehninger
Gerhard Ehninger
Professor of Internal Medicine
Verified email at
Cited by
Cited by
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis …
C Thiede, C Steudel, B Mohr, M Schaich, U Schäkel, U Platzbecker, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4326-4335, 2002
Mesenchymal stem cells can be differentiated into endothelial cells in vitro
J Oswald, S Boxberger, B Jørgensen, S Feldmann, G Ehninger, ...
Stem cells 22 (3), 377-384, 2004
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
N engl j Med 369, 111-121, 2013
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
C Thiede, S Koch, E Creutzig, C Steudel, T Illmer, M Schaich, G Ehninger, ...
Blood 107 (10), 4011-4020, 2006
Peripheral-blood stem cells versus bone marrow from unrelated donors
C Anasetti, BR Logan, SJ Lee, EK Waller, DJ Weisdorf, JR Wingard, ...
New England Journal of Medicine 367 (16), 1487-1496, 2012
Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
H Einsele, G Ehninger, H Hebart, KM Wittkowski, U Schuler, G Jahn, ...
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and …
T Fischer, RM Stone, DJ DeAngelo, I Galinsky, E Estey, C Lanza, E Fox, ...
Journal of clinical oncology 28 (28), 4339, 2010
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk …
C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ...
Journal of clinical oncology 25 (31), 4938-4945, 2007
Individual patient data–based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia …
RF Schlenk, A Benner, J Krauter, T Buchner, C Sauerland, G Ehninger, ...
Journal of Clinical Oncology 22 (18), 3741-3750, 2004
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, ...
Leukemia 26 (3), 381-389, 2012
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
A Neubauer, C Thiede, B Alpen, M Ritter, B Neubauer, G Ehninger, ...
Journal of the National Cancer Institute 89 (18), 1350-1355, 1997
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate
T Illmer, M Schaich, U Platzbecker, J Freiberg-Richter, U Oelschlägel, ...
Leukemia 18 (3), 401-408, 2004
Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective …
H Wandt, M Frank, G Ehninger, C Schneider, N Brack, A Daoud, ...
Blood, The Journal of the American Society of Hematology 91 (10), 3601-3606, 1998
Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer
M Florek, M Haase, AM Marzesco, D Freund, G Ehninger, WB Huttner, ...
Cell and tissue research 319 (1), 15-26, 2005
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
RF Chemaly, AJ Ullmann, S Stoelben, MP Richard, M Bornhäuser, ...
New England Journal of Medicine 370 (19), 1781-1789, 2014
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M Von Bonin, F Stölzel, A Goedecke, K Richter, N Wuschek, K Hölig, ...
Bone marrow transplantation 43 (3), 245-251, 2009
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 …
C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ...
The lancet oncology 16 (16), 1691-1699, 2015
Rapamycin extends murine lifespan but has limited effects on aging
F Neff, D Flores-Dominguez, DP Ryan, M Horsch, S Schröder, T Adler, ...
The Journal of clinical investigation 123 (8), 3272-3291, 2013
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
C Thiede, M Florek, M Bornhäuser, M Ritter, B Mohr, C Brendel, ...
Bone Marrow Transplantation 23 (10), 1055-1060, 1999
The system can't perform the operation now. Try again later.
Articles 1–20